Vitamin B3 Shows Promise Against Fatty Liver Disease in New Research
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for a safe, accessible treatment.
20 articles
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for a safe, accessible treatment.
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for 30% of people affected globally.
New rare sugar sweetener may reduce body fat and blood sugar, but research shows mixed results and potential digestive issues.
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors โ all with aging implications.
UC Riverside scientists developed a gel that delivers continuous oxygen to chronic wounds, healing fatal injuries in diabetic mice within weeks.
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
Yale researchers solved how coenzyme A from vitamin B5 enters mitochondria, unlocking new insights into metabolism and disease prevention.
New research shows diabetes and weight-loss medications slow alcohol absorption, making people feel less intoxicated and potentially reducing drinking.
Scientists discover how thin mountain air transforms red blood cells into glucose absorbers, explaining lower diabetes rates at elevation.
Reducing methionine and cysteine in diet activated calorie-burning beige fat as effectively as cold exposure, offering new weight loss insights.
New research identifies LRG1 protein as early trigger of diabetic retinopathy, opening door to prevention-based treatments.
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
New research shows ketogenic diet helps normalize blood sugar and dramatically improves muscle response to exercise in mice.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
Experimental diabetes drug IC7Fc reduces cholesterol and artery plaque buildup, offering cardiovascular benefits even without weight loss.
New research shows blood sugar can normalize without losing weight by shifting harmful belly fat to healthier locations under the skin.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
Yale study shows mindfulness training for stressed parents reduced childhood obesity risk more effectively than nutrition education alone.
Historical and modern evidence suggests fasting can reverse diabetes, but sustainable dietary changes are crucial for lasting results.
Large study of 8,000 patients reveals stopping GLP-1 drugs doesn't guarantee weight regain as many restart treatment or adopt lifestyle changes.